Abstract IA03: Immune Related Toxicities Associated with Immunotherapies
Chimeric antigen receptor T-cell (CART) therapy has revolutionized care for many pediatric cancers, especially relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). Although CART are highly effective, they can induce severe toxicities. The most common severe adverse events associated with CART are cytok...